UNC-45A’s Role in Microtubule Curvature and Cancer Treatment
Professor Martina Bazzaro's team found that the protein UNC-45A prefers to bind curved microtubules and bends them even in the presence of Taxol, which normally straightens them.
Read the original paper
Microtubules, crucial for cell division and structural integrity, play an essential role in the dynamics of cancer cells. Drugs like Taxol, used in chemotherapy, target these structures by stabilizing them to inhibit cell division. However, the discovery of UNC-45A, an ATP-independent microtubule-severing protein, introduces a new understanding of these dynamics.
Professor Martina Bazzaro and her team at the University of Minnesota, including Asumi Hoshino, Dr. Valentino Clemente, Mihir Shetty, Dr. Brian Castle, and Professor David Odde, have uncovered UNC-45A’s unique role in microtubule dynamics, opening up new avenues in cancer treatment research.
To explore the role of UNC-45A, the team employed a combination of in vitro biophysical reconstitution and total internal fluorescence microscopy analysis. They recreated cellular conditions in a controlled setting to observe how UNC-45A interacts with microtubules, focusing on its preference for binding to curved microtubules over straight ones. Additionally, they manipulated UNC-45A levels in cells to observe its impact on microtubule curvature.
Professor Bazzaro explains, “UNC-45A–mediated MT severing is preceded by the appearance of MT bends. While MTs are stiff biological polymers in cells, they often curve, and the result of this curving can be breaking off.” This insight highlights the unique mechanism by which UNC-45A influences microtubule behavior, a departure from the usual ATP-dependent severing proteins.
In a remarkable finding, the study reveals that UNC-45A induces curvature in microtubules even in the presence of Taxol. While Taxol is known to straighten microtubules, the team observed that Taxol-treated microtubules become less stiff and more wavy in vitro, yet straighten in cellular environments.
The implications of this discovery are profound for understanding cancer cell resistance to chemotherapy. Professor Bazzaro notes, “Despite this [straightening effect of Taxol], UNC-45A retains its ability to induce curvature in Paclitaxel-exposed MTs.” This suggests that UNC-45A might play a role in the development of chemoresistance in cancer cells, presenting new challenges and opportunities for therapeutic intervention.
The research is pivotal not only in oncology but also in understanding other conditions involving disrupted microtubule dynamics, such as neurodegenerative diseases. The unique ATP-independent mechanism of UNC-45A may offer an advantage in diseases characterized by reduced ATP levels and high oxidative stress.
In conclusion, the University of Minnesota’s research provides critical insights into UNC-45A’s role in microtubule dynamics and opens up new possibilities for treating diseases where microtubule stability is crucial. The findings pave the way for more effective and targeted therapies, enriching our understanding of cellular structures and their interactions with drugs.
About the researcher
Journal reference
Martina Bazzaro, Asumi Hoshino, Valentino Clemente, Mihir Shetty, Brian Castle, David Odde, “The microtubule-severing protein UNC-45A preferentially binds to curved microtubules and counteracts the microtubule-straightening effects of Taxol,” Journal of Biological Chemistry, 2023. DOI: https://doi.org/10.1016/j.jbc.2023.105355



